- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- N/A
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Dominick J Angiolillo, MD, PhD
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 409 publications
- Percutaneous Coronary Intervention , 206 publications
- Clopidogrel , 186 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
My publications
Filter publications
822 publications
2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
鈥�2024
Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study.
European heart journal. Cardiovascular pharmacotherapy
鈥�2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.
JAMA cardiology
鈥�2024
Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention
Circulation: Cardiovascular Interventions
2024
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score.
Journal of the American College of Cardiology
鈥�